Literature DB >> 2961702

Identification of C3d receptors on Candida albicans.

R A Calderone1, L Linehan, E Wadsworth, A L Sandberg.   

Abstract

Pseudohyphal but not yeast forms of Candida albicans possess both iC3b and C3d receptors, as determined by rosetting with erythrocytes carrying iC3b (EAC3bi) or C3d (EAC3d). Rosetting with EAC3d was markedly reduced when pseudohyphae were heat killed or treated with trypsin or pronase but was not inhibited by several saccharides or aminosaccharides, including alpha-methyl-D-mannoside, or by pretreatment of pseudohyphae with concanavalin A. However, mannoproteins obtained by concanavalin A affinity chromatography of whole pseudohyphal extracts inhibited the attachment of EAC3d to C. albicans, whereas soluble (nonmannosylated) proteins were less active. Thus, although the C3d receptors appeared to be glycosylated, the oligosaccharide component of the receptor was apparently not involved in the recognition of C3d. To isolate these receptors, whole-cell extracts were separated by DEAE-Trisacryl chromatography. Fractions that inhibited rosetting were pooled and affinity purified by C3d-Thiol-Sepharose chromatography. The eluate from this affinity column inhibited attachment of C. albicans to EAC3d. Monoclonal antibodies to C. albicans were prepared, and three of these antibodies blocked rosetting. Western blotting (immunoblotting) with these antibodies indicated the presence of 62- and 70-kilodalton receptors for C3d in the extracts purified by C3d affinity chromatography and separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2961702      PMCID: PMC259265          DOI: 10.1128/iai.56.1.252-258.1988

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  18 in total

1.  Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3.

Authors:  D P Vik; D T Fearon
Journal:  J Immunol       Date:  1985-04       Impact factor: 5.422

2.  Identification and characterization of a cellular protein that cross-reacts with the Epstein-Barr virus nuclear antigen.

Authors:  J Luka; T Kreofsky; G R Pearson; K Hennessy; E Kieff
Journal:  J Virol       Date:  1984-12       Impact factor: 5.103

3.  Cell wall proteins of Candida albicans.

Authors:  W L Chaffin; D M Stocco
Journal:  Can J Microbiol       Date:  1983-10       Impact factor: 2.419

4.  Regulation of immunoglobulin expression in mouse myeloma cells.

Authors:  D H Margulies; W Cieplinski; B Dharmgrongartama; M L Gefter; S L Morrison; T Kelly; M D Scharff
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1977

5.  The identification of N-linked oligosaccharides on the human CR2/Epstein-Barr virus receptor and their function in receptor metabolism, plasma membrane expression, and ligand binding.

Authors:  J J Weis; D T Fearon
Journal:  J Biol Chem       Date:  1985-11-05       Impact factor: 5.157

6.  Identification of a 145,000 Mr membrane protein as the C3d receptor (CR2) of human B lymphocytes.

Authors:  J J Weis; T F Tedder; D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

7.  Characterization of cerulenin-resistant mutants of Candida albicans.

Authors:  K A Hoberg; R L Cihlar; R A Calderone
Journal:  Infect Immun       Date:  1986-01       Impact factor: 3.441

8.  Candida albicans and Candida stellatoidea, in contrast to other Candida species, bind iC3b and C3d but not C3b.

Authors:  F Heidenreich; M P Dierich
Journal:  Infect Immun       Date:  1985-11       Impact factor: 3.441

9.  Isolation of lymphocyte membrane complement receptor type two (the C3d receptor) and preparation of receptor-specific antibody.

Authors:  J D Lambris; N J Dobson; G D Ross
Journal:  Proc Natl Acad Sci U S A       Date:  1981-03       Impact factor: 11.205

10.  Identification of the membrane receptor for the complement fragment C3d by means of a monoclonal antibody.

Authors:  K Iida; L Nadler; V Nussenzweig
Journal:  J Exp Med       Date:  1983-10-01       Impact factor: 14.307

View more
  51 in total

1.  Characterization of cell wall proteins from yeast and mycelial cells of Candida albicans by labelling with biotin: comparison with other techniques.

Authors:  M Casanova; J L Lopez-Ribot; J P Martinez; R Sentandreu
Journal:  Infect Immun       Date:  1992-11       Impact factor: 3.441

2.  Purification and biochemical characterization of a 65-kilodalton mannoprotein (MP65), a main target of anti-Candida cell-mediated immune responses in humans.

Authors:  M J Gomez; A Torosantucci; S Arancia; B Maras; L Parisi; A Cassone
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

3.  Biochemical and immunological characterization of MP65, a major mannoprotein antigen of the opportunistic human pathogen Candida albicans.

Authors:  M J Gomez; B Maras; A Barca; R La Valle; D Barra; A Cassone
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

Review 4.  Adherence and receptor relationships of Candida albicans.

Authors:  R A Calderone; P C Braun
Journal:  Microbiol Rev       Date:  1991-03

Review 5.  Cell wall and secreted proteins of Candida albicans: identification, function, and expression.

Authors:  W L Chaffin; J L López-Ribot; M Casanova; D Gozalbo; J P Martínez
Journal:  Microbiol Mol Biol Rev       Date:  1998-03       Impact factor: 11.056

6.  History of medical mycology in the united states.

Authors:  A Espinel-Ingroff
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

7.  Complex interaction between different proteinaceous components within the cell-wall structure of Candida albicans.

Authors:  J L Lopez-Ribot; D A Cortlandt; D C Straus; K J Morrow; W L Chaffin
Journal:  Mycopathologia       Date:  1995-11       Impact factor: 2.574

8.  Hydrophobic surface protein masking by the opportunistic fungal pathogen Candida albicans.

Authors:  K C Hazen; B W Hazen
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

9.  Mechanisms of adherence of Candida albicans to cultured human epidermal keratinocytes.

Authors:  M W Ollert; R Söhnchen; H C Korting; U Ollert; S Bräutigam; W Bräutigam
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

10.  Cell extracts of Candida albicans block adherence of the organisms to endothelial cells.

Authors:  J E Edwards; C L Mayer; S G Filler; E Wadsworth; R A Calderone
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.